alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# EUR-Lex - 31990R0770 - EN

Avis juridique important

*|*

# 31990R0770

**Commission Regulation (Euratom) No 770/90 of 29 March 1990 laying down maximum permitted levels of radioactive contamination of feedingstuffs following a nuclear accident or any other case of radiological emergency **

*
Official Journal L 083 , 30/03/1990 P. 0078 - 0079 Finnish special edition: Chapter 15 Volume 9 P. 0185 Swedish special edition: Chapter 15 Volume 9 P. 0185 *

*****

COMMISSION REGULATION (EURATOM) No 770/90

of 29 March 1990

laying down maximum permitted levels of radioactive contamination of feedingstuffs following a nuclear accident or any other case of radiological emergency

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community,

Having regard to Council Regulation (Euratom) No 3954/87 of 22nd December 1987 laying down maximum permitted levels of radioactive contamination of foodstuffs and of feedingstuffs following a nuclear accident or any other case of radiological emergency (1), as amended by Regulation (Euratom) No 2218/89 (2), and in particular Article 7 thereof,

Whereas, in accordance with Regulation (Euratom) No 3954/87, the Commission shall adopt maximum levels of radioactive contamination to be applied to feedingstuffs;

Whereas the group of experts appointed by the Scientific and Technical Committee pursuant to Article 31 of the Euratom Treaty, has been consulted;

Whereas consideration of the relative quantities of individual radionuclides liable to be released in the event of a nuclear accident in conjunction with their half-lives and transfer from feedingstuffs to animal produce leads to the conclusion that maximum permitted levels of radioactive contamination of feedingstuffs are needed only for the caesium isotopes;

Whereas the measures provided for in this Regulation are in accordance with the opinion of the ad hoc Committe instituted by Regulation (Euratom) No 3954/87,

HAS ADOPTED THIS REGULATION:

Article 1

Maximum permitted levels of radioactive contamination of feedingstuffs are set out in the Annex.

Article 2

This Regulation shall enter into force on the third day following its publication in the Official Journal of the European Communities.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 29 March 1990.

For the Commission

Carlo RIPA DI MEANA

Member of the Commission

(1) OJ No L 371, 30. 12. 1987, p. 11.

(2) OJ No L 211, 22. 7. 1989, p. 1.

ANNEX

Maximum permitted levels of radiactive contamination (caesium-134 and caesium-137) of feedingstuffs

1.2 // // // Animal // Bq/kg (1) (2) // // // Pigs // 1 250 // Poultry, lambs, calves // 2 500 // Other // 5 000 // //

(1) These levels are intended to contribute to the observance of the maximum permitted levels for foodstuffs; they do not alone guarantee such observance in all circumstances and do not lessen the requirement for monitoring contamination levels in animal products destined for human consumption.

(2) These levels apply to feedingstuffs as ready for consumption.
Editorial Note on Part 314
Editorial Note: Nomenclature changes to part 314 appear at 69 FR 13717, Mar. 24, 2004; 81 FR 69639, Oct. 6, 2016.

§ 314.520 Approval with restrictions to assure safe use. ( a ) If FDA concludes that a drug product shown to be effective can be safely used only if distribution or use is restricted, FDA will require such postmarketing restrictions as are needed to assure safe use of the drug product, such as: ( 1 ) Distribution restricted to certain facilities or physicians with special training or experience; or
( 2 ) Distribution conditioned on the performance of specified medical procedures.
( b ) The limitations imposed will be commensurate with the specific safety concerns presented by the drug product.
<PAGE>   1
                                                                   Exhibit 23(a)

                        INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference in this Prospectus Supplement
dated June 23, 1999 to the Registration Statement of Aristar, Inc. on Form S-3,
as supplemented by the Prospectus dated June 22, 1999, of our report dated
January 19, 1999, appearing in the Annual Report on Form 10-K of Aristar, Inc.
for the year ended December 31, 1998 and to the reference to us under the
heading "Experts" in the Prospectus Supplement, which is part of the
Registration Statement.

/s/ Deloitte & Touche LLP

June 23, 1999
Tampa, Florida
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                         787,544
<SECURITIES>                                         0
<RECEIVABLES>                                  378,862
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                      15,896,007
<DEPRECIATION>                               6,574,606
<TOTAL-ASSETS>                              15,229,279
<CURRENT-LIABILITIES>                       21,067,133
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                 (5,837,854)
<TOTAL-LIABILITY-AND-EQUITY>                15,229,279
<SALES>                                      4,959,668
<TOTAL-REVENUES>                             4,959,668
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             4,025,941
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             832,098
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (20,098)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
# Missouri Court of Appeals

Southern District

MAY 22, 2015

THE FOLLOWING CASES WERE AFFIRMED IN ACCORDANCE WIT H RULE 84.16(b).

1. SD33418 DON STEWART, et al., Respondent

vs. SPOKANE R-VII SCHOOL DISTRICT, Appellant
[Federal Register Volume 75, Number 7 (Tuesday, January 12, 2010)]
[Notices]
[Page 1680]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-358]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice 6864]


Culturally Significant Objects Imported for Exhibition 
Determinations: ``Roman Art''

SUMMARY: Notice is hereby given of the following determinations: 
Pursuant to the authority vested in me by the Act of October 19, 1965 
(79 Stat. 985; 22 U.S.C. 2459), Executive Order 12047 of March 27, 
1978, the Foreign Affairs Reform and Restructuring Act of 1998 (112 
Stat. 2681, et seq.; 22 U.S.C. 6501 note, et seq.), Delegation of 
Authority No. 234 of October 1, 1999, Delegation of Authority No. 236 
of October 19, 1999, as amended, and Delegation of Authority No. 257 of 
April 15, 2003 [68 FR 19875], I hereby determine that the objects to be 
included in the exhibition ``Roman Art,'' imported from abroad for 
temporary exhibition within the United States, are of cultural 
significance. The objects are imported pursuant to loan agreements with 
the foreign owners or custodians. I also determine that the exhibition 
or display of the exhibit objects at the Metropolitan Museum of Art, 
New York, NY, from on or about January 2010 until on or about January 
2014, and at possible additional exhibitions or venues yet to be 
determined, is in the national interest. Public Notice of these 
Determinations is ordered to be published in the Federal Register.

FOR FURTHER INFORMATION CONTACT: For further information, including a 
list of the exhibit objects, contact Carol B. Epstein, Attorney-
Adviser, Office of the Legal Adviser, U.S. Department of State 
(telephone: 202/632-6473). The address is U.S. Department of State, SA-
5, L/PD, Fifth Floor, Washington, DC 20522-0505.

    Dated: January 4, 2010.
Maura M. Pally,
Deputy Assistant Secretary for Professional and Cultural Exchanges, 
Bureau of Educational and Cultural Affairs, Department of State.
[FR Doc. 2010-358 Filed 1-11-10; 8:45 am]
BILLING CODE 4710-05-P
### D ISTRICT 

### C OURT 

### O F 

### A PPEAL 

### O F 

### T HE 

### S TATE 

### O F 

### F LORIDA

F OURTH D ISTRICT

RENITA CHARLES

, Appellant,

v.

C LIFFORD CHARLES

, Appellee.

No. 4D 2 02 3

- 1812

[ May 23, 2024 ]

Appeal from the Circuit Court for the Seventeenth Judicial Circuit,

Broward County; Susan Lebow, Senior Judge; L.T. Case No. FMCE23

-

000221.

Renita Charles, Pembroke Pines, pro se.

No appearance for appellee.

P ER C URIAM

.

Affirmed.

C IKLIN

, G ERBER and A RTAU

, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
Editorial Note on Part 184
Editorial Note: Nomenclature changes to part 184 appear at 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 69 FR 13717, Mar. 24, 2004; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; and 81 FR 49897, July 29, 2016.

§ 184.1307c Ferrous citrate. ( a ) Ferrous citrate (iron (II) citrate, (C6H6FeO7), CAS Reg. No. 23383-11-1) is a slightly colored powder or white crystals. It is prepared from the reaction of sodium citrate with ferrous sulfate or by direct action of citric acid on iron filings.
( b ) The ingredient must be of a purity suitable for its intended use.
( c ) In accordance with § 184.1(b)(1) the ingredient is used in food as a nutrient supplement as defined in § 170.3(o)(20) of this chapter, with no limitation other than current good manufacturing practice. The ingredient may also be used in infant formula in accordance with section 412(g) of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 350a(g)) or with regulations promulgated under section 412(a)(2) of the act (21 U.S.C. 350a(a)(2)).
( d ) Prior sanctions for this ingredient different from the uses established in this section do not exist or have been waived.
[53 FR 16866, May 12, 1988, as amended at 73 FR 8607, Feb. 14, 2008]
# EUR-Lex - 31987R3179 - EN

Avis juridique important

*|*

# 31987R3179

**Commission Regulation (EEC) No 3179/87 of 23 October 1987 amending Regulation (EEC) No 2984/87 as regards the buying in of common wheat of breadmaking quality **

*
Official Journal L 301 , 24/10/1987 P. 0039 - 0039 *

*****

COMMISSION REGULATION (EEC) No 3179/87

of 23 October 1987

amending Regulation (EEC) No 2984/87 as regards the buying in of common wheat of breadmaking quality

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community,

Having regard to Council Regulation (EEC) No 2727/75 of 29 October 1975 on the common organization of the market in cereals (1), as last amended by Regulation (EEC) No 1900/87 (2), and in particular Article 7 (3) thereof,

Whereas Regulation (EEC) No 2727/75 lays down, in Article 7, the conditions in which buying-in must cease; whereas the general rules on intervention are laid down in Council Regulation (EEC) No 1581/86 of 23 May 1986 laying down general rules for intervention on the market in cereals (3); whereas the detailed rules of application of that Regulation are laid down in Commission Regulation (EEC) No 2232/87 of 23 July 1987 laying down detailed rules applying to intervention purchasing of cereals (4);

Whereas Commission Regulation (EEC) No 2984/87 (5) opened intervention throughout the Community, in particular for common wheat; whereas, in the light of the provisions referred to above, the buying-in of common wheat of breadmaking quality should cease throughout the Community;

Whereas the measures provided for in this Regulation are in accordance with the opinion of the Management Committee for Cereals,

HAS ADOPTED THIS REGULATION:

Article 1

Article 1 of Regulation (EEC) No 2984/87 is replaced by the following:

'Article 1

The intervention agencies shall buy in common wheat, durum wheat, barley and rye offered to them. However, the reduction referred to in Article 4a (1) of Commission Regulation (EEC) No 1570/77 (1) shall apply to any common wheat offered.'

(1) OJ No L 174, 14. 7. 1977, p. 18.

Article 2

Commission Regulation (EEC) No 2421/87 (6) is hereby repealed.

Article 3

This Regulation shall enter into force on the day of its publication in the Official Journal of the European Communities.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 23 October 1987.

For the Commission

Frans ANDRIESSEN

Vice-President

(1) OJ No L 281, 1. 11. 1975, p. 1.

(2) OJ No L 182, 3. 7. 1987, p. 40.

(3) OJ No L 139, 24. 5. 1986, p. 36.

(4) OJ No L 206, 28. 7. 1987, p. 16.

(5) OJ No L 283, 6. 10. 1987, p. 10.

(6) OJ No L 223, 11. 8. 1987, p. 10.
Editorial Note on Part 201
Editorial Note: Nomenclature changes to part 201 appear at 69 FR 13717, Mar. 24, 2004.

§ 201.63 Pregnancy/breast-feeding warning. ( a ) The labeling for all over-the-counter (OTC) drug products that are intended for systemic absorption, unless specifically exempted, shall contain a general warning under the heading “Warning” (or “Warnings” if it appears with additional warning statements) as follows: “If pregnant or breast-feeding, ask a health professional before use.” [first four words of this statement in bold type] In addition to the written warning, a symbol that conveys the intent of the warning may be used in labeling.
( b ) Where a specific warning relating to use during pregnancy or while nursing has been established for a particular drug product in a new drug application (NDA) or for a product covered by an OTC drug final monograph in part 330 of this chapter, the specific warning shall be used in place of the warning in paragraph (a) of this section, unless otherwise stated in the NDA or in the final OTC drug monograph.
( c ) The following OTC drugs are exempt from the provisions of paragraph (a) of this section: ( 1 ) Drugs that are intended to benefit the fetus or nursing infant during the period of pregnancy or nursing.
( 2 ) Drugs that are labeled exclusively for pediatric use.
( d ) The Food and Drug Administration will grant an exemption from paragraph (a) of this section where appropriate upon petition under the provisions of § 10.30 of this chapter. Decisions with respect to requests for exemptions shall be maintained in a permanent file for public review by the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.
( e ) The labeling of orally or rectally administered OTC aspirin and aspirin-containing drug products must bear a warning that immediately follows the general warning identified in paragraph (a) of this section. The warning shall be as follows:
“It is especially important not to use” (select “aspirin” or “carbaspirin calcium,” as appropriate) “during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.”
[47 FR 54757, Dec. 3, 1982, as amended at 55 FR 27784, July 5, 1990; 59 FR 14364, Mar. 28, 1994; 64 FR 13286, Mar. 17, 1999; 68 FR 24879, May 9, 2003; 88 FR 45065, July 14, 2023]
#### § 20.67 Records exempted by other statutes.

Records or information may be withheld from public disclosure if a statute specifically allows the Food and Drug Administration (FDA) to withhold them. FDA may use another statute to justify withholding records and information only if it absolutely prohibits disclosure, sets forth criteria to guide our decision on releasing material, or identifies particular types of matters to be withheld.

[70 FR 41958, July 21, 2005]
#### § 205.4 Wholesale drug distributor licensing requirement.

Every wholesale distributor in a State who engages in wholesale distributions of prescription drugs in interstate commerce must be licensed by the State licensing authority in accordance with this part before engaging in wholesale distributions of prescription drugs in interstate commerce.
§ 1311.210 Archiving the initial record. ( a ) Except as provided in paragraph (c) of this section, a copy of each electronic controlled substance prescription record that a pharmacy receives must be digitally signed by one of the following: ( 1 ) The last intermediary transmitting the record to the pharmacy must digitally sign the prescription immediately prior to transmission to the pharmacy.
( 2 ) The first pharmacy application that receives the electronic prescription must digitally sign the prescription immediately on receipt.
( b ) If the last intermediary digitally signs the record, it must forward the digitally signed copy to the pharmacy.
( c ) If a pharmacy receives a digitally signed prescription that includes the individual practitioner's digital signature, the pharmacy application must do the following: ( 1 ) Verify the digital signature as provided in FIPS 186-3, as incorporated by reference in § 1311.08.
( 2 ) Check the validity of the certificate holder's digital certificate by checking the certificate revocation list. The pharmacy may cache the CRL until it expires.
( 3 ) Archive the digitally signed record. The pharmacy record must retain an indication that the prescription was verified upon receipt. No additional digital signature is required.
Editorial Note on Part 184
Editorial Note: Nomenclature changes to part 184 appear at 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 69 FR 13717, Mar. 24, 2004; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; and 81 FR 49897, July 29, 2016.

§ 184.1505 Mono- and diglycerides. ( a ) Mono- and diglycerides consist of a mixture of glyceryl mono- and diesters, and minor amounts of triesters, that are prepared from fats or oils or fat-forming acids that are derived from edible sources. The most prevalent fatty acids include lauric, linoleic, myristic, oleic, palmitic, and stearic. Mono- and diglycerides are manufactured by the reaction of glycerin with fatty acids or the reaction of glycerin with triglycerides in the presence of an alkaline catalyst. The products are further purified to obtain a mixture of glycerides, free fatty acids, and free glycerin that contains at least 90 percent-by-weight glycerides.
( b ) The ingredient meets the specifications of the Food Chemicals Codex, 3d Ed. (1981), p. 201, which is incorporated by reference in accordance with 5 U.S.C. 552(a). Copies are available from the National Academy Press, 2101 Constitution Ave. NW., Washington, DC 20418, or available for inspection at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html .*
( c ) In accordance with § 184.1(b)(1), the ingredient is used in food with no limitation other than current good manufacturing practice. The affirmation of this ingredient as generally recognized as safe (GRAS) as a direct human food ingredient is based upon the following current good manufacturing practice conditions of use: ( 1 ) The ingredient is used in food as a dough strengthener as defined in § 170.3(o)(6) of this chapter; an emulsifier and emulsifier salt as defined in § 170.3(o)(8) of this chapter; a flavoring agent and adjuvant as defined in § 170.3(o)(12) of this chapter; a formulation aid as defined in § 170.3(o)(14) of this chapter; a lubricant and release agent as defined in § 170.3(o)(18) of this chapter; a solvent and vehicle as defined in § 170.3(o)(27) of this chapter; a stabilizer and thickener as defined in § 170.3(o)(28) of this chapter; a surface-active agent as defined in § 170.3(o)(29) of this chapter; a surface-finishing agent as defined in § 170.3(o)(30) of this chapter; and a texturizer as defined in § 170.3(o)(32) of this chapter.
( 2 ) The ingredient is used in food at levels not to exceed current good manufacturing practice.
( d ) Prior sanctions for this ingredient different from the uses established in this section do not exist or have been waived.
[54 FR 7403, Feb. 21, 1989, as amended at 57 FR 10616, Mar. 27, 1992]
**UNITED STATES ENVIRONMENTAL PROTECTION AGENCY** NATIONAL VEHICLE AND FUEL EMISSIONS LABORATORY

2000 TRAVERWOOD ROAD ANN ARBOR, MI 48105
- 2498

OFFICE OF AIR AND RADIATION December 29 , 2010 MEMORANDUM SUBJECT: Meeting with Aluminum Association FROM: Angela Cullen, Mechanical Engineer TO: Docket EPA
- HQ
- OAR
- 2010
- 0162 This memorandum documents a meeting held on Fri day , December 17 , 2010 b etween the Aluminum Association , EPA, and DOT . The attendees included: Aluminum Association: Brian Tucker, Randall Scheps, and Doug Richman EPA: By ron Bunker , Cle Jackson, Cheryl By num , and Angela Cullen DOT : Maurice Hicks , Ryan Harrington, Lixin Zhao The discussion focused primarily on lightweighting opportunities in heavy duty vehicles
.
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7385 Reported in Senate (RS)]

<DOC>

                                                       Calendar No. 540
118th CONGRESS
  2d Session
                                H. R. 7385

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             July 23, 2024

Received; read twice and referred to the Committee on Homeland Security 
                        and Governmental Affairs

                           September 25, 2024

               Reported by Mr. Peters, without amendment

_______________________________________________________________________

                                 AN ACT

 
 To designate the facility of the United States Postal Service located 
  at 29 Franklin Street in Petersburg, Virginia, as the ``John Mercer 
                    Langston Post Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. JOHN MERCER LANGSTON POST OFFICE BUILDING.

    (a) Designation.--The facility of the United States Postal Service 
located at 29 Franklin Street in Petersburg, Virginia, shall be known 
and designated as the ``John Mercer Langston Post Office Building''.
    (b) References.--Any reference in a law, map, regulation, document, 
paper, or other record of the United States to the facility referred to 
in subsection (a) shall be deemed to be a reference to the ``John 
Mercer Langston Post Office Building''.
                                                       Calendar No. 540

118th CONGRESS

  2d Session

                               H. R. 7385

_______________________________________________________________________

                                 AN ACT

 To designate the facility of the United States Postal Service located 
  at 29 Franklin Street in Petersburg, Virginia, as the ``John Mercer 
                    Langston Post Office Building''.

_______________________________________________________________________

                           September 25, 2024

                       Reported without amendment
```